Treatment instrument for endocrinology department
By using an automated electrode release system and an electro-responsive adhesive layer, the problems of cumbersome operation and skin irritation associated with existing electrostimulation therapy devices have been solved, enabling precise and safe treatment of diabetic neuropathy and improving the stability of current conduction and patient comfort.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-12-26
- Publication Date
- 2026-04-03
AI Technical Summary
Existing electrical stimulation therapy devices for diabetic neuropathy are cumbersome to operate, pose a high risk of skin irritation, have unstable current conduction, and are prone to infection due to adhesive residue. Uneven application of conductive gel can also reduce the therapeutic effect.
The electrode mechanism, which incorporates a built-in battery and Bluetooth module, combined with an automated feeding mechanism and an electrically responsive adhesive layer, enables automated release and precise positioning of the electrodes. A vortex-type liquid distribution tank ensures uniform penetration of the conductive gel, while wireless charging and ultraviolet sterilization ensure stable current conduction and aseptic processing.
This technology enables automated, precise, and safe electrode treatment, reduces operational difficulty, minimizes the risk of skin irritation, improves the stability of current conduction and patient comfort, and avoids cross-infection.
Smart Images

Figure CN121775320A_ABST
Abstract
Description
Technical Field
[0001] This application relates to the field of diabetes treatment devices, and in particular to a treatment device for endocrinology. Background Technology
[0002] Diabetic peripheral neuropathy is a common complication of diabetes in endocrinology departments, mainly manifested as sensory abnormalities, numbness, and pain in the distal extremities, severely impacting patients' quality of life. Currently, electrical stimulation therapy is commonly used clinically to alleviate this condition. Electrodes are attached to the affected area to release low-frequency pulsed currents that stimulate nerve endings, thereby improving nerve conduction and reducing pain.
[0003] The existing electrode pads used for the treatment of diabetic neuropathy are mostly single-piece structures. Medical staff need to manually locate the lesion area, peel off the protective film on the back of each pad, and then stick them on. The operation process is cumbersome and it is difficult to ensure the uniform distribution and precise positioning of multiple sets of electrode pads. This can easily lead to omissions or overlaps in the treatment area, which directly affects the effect of electrical stimulation treatment. Furthermore, the existing electrode pads mostly use medical pressure-sensitive adhesive layers for bonding. When peeling them off after bonding, adhesive residue is easily left on the skin surface. Diabetic patients have weak skin healing ability and high sensitivity. Adhesive residue can not only cause skin irritation such as itching and redness, but in severe cases, it may also lead to skin damage, which in turn can cause complications such as infection and ulceration. Meanwhile, the conductive gel on the existing electrode pads needs to be applied manually before application. The amount applied depends entirely on experience. Too little will hinder current conduction, while too much will easily overflow and stain clothing. Uneven application will also cause inconsistent contact resistance between the electrode pad and the skin, resulting in uneven current distribution, local stinging sensation, and reduced treatment effectiveness.
[0004] To address the above technical issues, a therapeutic device for endocrinology is proposed. Summary of the Invention
[0005] The purpose of this application is to address the technical problems of existing diabetic neuropathy electrical stimulation therapy devices, such as cumbersome operation, high risk of skin irritation, and unstable current conduction, and to provide an endocrinology therapy device that includes: The electrode mechanism, consisting of several electrode mechanisms in pairs, is attached to the neuropathy area of a diabetic patient for electrical stimulation therapy. The electrode mechanism has a built-in battery and Bluetooth module for power supply and wireless control. The feeding mechanism has an overall ring structure and is used to support the electrode mechanism at evenly spaced angles. The outer shell mechanism is used to cover the feeding mechanism and sequentially release the electrode mechanism on the feeding mechanism to the neuropathic area; A touchscreen display is used to control and display the current intensity of each electrode mechanism.
[0006] Furthermore, the electrode mechanism includes a circular shell and a top cover, with a circuit board encapsulated between the circular shell and the top cover. The bottom of the circular shell is fixed with a limiting skirt for pressing against the substrate. The battery and Bluetooth module are both mounted on the circuit board, and the circuit board is also equipped with an indicator light. The bottom of the circular shell is provided with an electrode substrate, the top of the electrode substrate is fixed with a conductive retaining ring, and the bottom of the circular shell is provided with a conductive snap groove that matches the conductive retaining ring; an adhesive substrate is sandwiched between the circular shell and the electrode substrate, and an electroresponsive adhesive layer is fixed on the side of the adhesive substrate to generate adhesion after being energized. Electrode plates are fixed to the bottom of the electrode substrate to generate current when energized. The battery supplies power to the electrode plates and the electro-responsive adhesive layer through a conductive retaining ring.
[0007] Furthermore, symmetrical limit grooves are provided on both sides of the circular shell; The feeding mechanism includes an annular base plate, on which elastic clamps corresponding to the number of electrode mechanisms are provided. The elastic clamps cover the circumferential side of the circular shell. The annular base plate also has two sets of symmetrically arranged tension rings. The tension rings include an elastic part and a clamping part. The clamping part extends into the elastic clamp and abuts against the limiting groove. The elastic part has an elastic force that drives the clamping part and the elastic clamp to approach the circular shell.
[0008] Furthermore, annular slide rails and drive gear rings are symmetrically fixed on both sides of the annular substrate. The outer shell mechanism includes an annular shell, which has an annular shell structure. The annular shell has an annular groove that matches the annular slide rail. The entire feeding mechanism is rotatably connected to the annular shell through the annular groove and the annular slide rail. The annular shell has a drive motor that drives the drive gear ring. The entire feeding mechanism rotates at equal angles within the annular shell through the drive motor. The bottom of the annular shell is provided with a release chamber, and the two sides of the release chamber are symmetrically and rotatably connected with chamber cover plates.
[0009] Furthermore, an execution handle is fixed at the center of the annular shell, the touch screen is fixed to the top of the execution handle, an execution mechanism is provided inside the execution handle, the execution mechanism includes an execution slide rod slidably connected to the bottom of the execution handle, a return spring is clamped between the execution slide rod and the execution handle, and an execution motor is provided inside the execution handle to drive the execution slide rod to move downward against the elastic force of the return spring. The bottom end of the execution slide rod is arranged opposite to the opening side of the release chamber.
[0010] Furthermore, the top of the electrode sheet is provided with a lower vortex groove, and the bottom of the electrode substrate is provided with an upper vortex groove corresponding to the lower vortex groove. The lower vortex groove and the upper vortex groove are aligned to form a vortex liquid distribution groove. The lower vortex groove is provided with a liquid distribution hole that communicates with the vortex liquid distribution groove. The electrode substrate is provided with a one-way input valve that communicates with the input point of the vortex liquid distribution tank. A replaceable liquid bladder is also clamped between the circular shell and the electrode substrate. The top of the one-way input valve is provided with a piercing needle that cooperates with the replaceable liquid bladder. The top of the replaceable liquid bladder is provided with a one-way guide tube. The top of the top cover is provided with a corresponding interface to the one-way guide tube. The top of the one-way guide tube passes through the circular shell and extends into the interface.
[0011] Furthermore, the circular shell is also fixed with an elastic electromagnetic sheet at the top of the replaceable liquid bladder, and the electrode substrate is fixed with a permanent magnet at the bottom of the replaceable liquid bladder. The elastic electromagnetic sheet has a magnetic attraction force on the permanent magnet when energized.
[0012] Furthermore, the actuator is also provided with a liquid guiding mechanism, which includes a liquid guiding tube fixed in the actuator slide rod. The bottom end of the liquid guiding tube extends through the actuator slide rod and is fixed with an injection port that cooperates with the unidirectional guide tube. The outer wall of the actuator handle is provided with a liquid supply tank, which includes a cleaning tank and a conductive tank. The cleaning tank is filled with disinfectant cleaning solution, and the conductive tank is filled with conductive gel. The actuator handle is also provided with a liquid supply pump and a two-position three-way solenoid valve. The output ends of the cleaning tank and the conductive tank are selectively connected to the input end of the liquid supply pump through the two-position three-way solenoid valve. The output end of the liquid supply pump is connected to the input end of the liquid guide tube.
[0013] Furthermore, an ultraviolet germicidal lamp is fixed to the outer ring side of the inner wall of the annular shell. The irradiation side of the ultraviolet germicidal lamp is arranged opposite to the electro-responsive adhesive layer of the electrode mechanism, which is used to sterilize the part of the electrode mechanism that comes into contact with the patient.
[0014] Furthermore, a wireless charging transmitter module is fixed to the inner ring side of the inner wall of the annular shell, and a wireless charging receiver module that cooperates with the wireless charging transmitter module is fixed inside the top cover.
[0015] Compared to existing technologies, the advantages of this application are: This invention utilizes a feeding mechanism and an actuator to automatically release electrodes, eliminating the need for manual application and significantly reducing operational difficulty. It employs an electrically responsive adhesive layer instead of traditional adhesive layers, achieving adhesion upon energization and loss of adhesion upon de-energization, leaving no adhesive residue. This design is suitable for the sensitive skin of diabetic patients, reducing the risk of infection. Furthermore, the adhesion is wirelessly controllable, enhancing convenience. A vortex-shaped liquid distribution groove and distribution holes ensure uniform penetration of the conductive gel, guaranteeing stable current and avoiding stinging sensations. A replaceable liquid bladder prevents cross-infection, and Bluetooth wireless communication combined with a built-in battery eliminates the need for wires, improving patient comfort. This invention achieves automated, precise, and safe electrical stimulation therapy for diabetic neuropathy, demonstrating high clinical application value. Attached Figure Description
[0016] Figure 1 This is a schematic diagram of the front structure of this application; Figure 2 This is a schematic diagram of the bottom structure of this application; Figure 3 This is an exploded view of the outer shell mechanism and the feeding mechanism proposed in this application; Figure 4 This is an exploded structural diagram of the feeding mechanism and electrode mechanism proposed in this application; Figure 5 This is an exploded structural diagram of the electrode mechanism proposed in this application; Figure 6 This is a schematic diagram of the exploded structure of the feed mechanism proposed in this application; Figure 7 This is a partial cross-sectional structural diagram of the feeding mechanism clamping the electrode mechanism proposed in this application; Figure 8 for Figure 7 Enlarged structural diagram of section A in the middle; Figure 9 This is a schematic diagram of the internal structure of the outer shell mechanism proposed in this application; Figure 10 This is a schematic diagram of the internal structure of the electrode substrate and electrode sheet proposed in this application; Figure 11 This is a schematic diagram of the overall cross-sectional structure of this application; Figure 12 This is a schematic diagram showing the before and after states of the actuator drive electrode mechanism as it moves downward, as proposed in this application. Figure 13 This is a partial cross-sectional structural diagram of the actuator when it is lowered, as proposed in this application. Figure 14 This is a cross-sectional structural diagram of the electrode mechanism proposed in this application; Figure 15 This is a perspective view of the structure of the elastic electromagnetic sheet and replaceable liquid bladder proposed in this application. Figure 16 This is a schematic diagram showing the arrangement of the electrode mechanism proposed in this application within the housing mechanism.
[0017] Explanation of the labels in the diagram: 1. Outer shell mechanism; 101. Release port; 11. Annular shell; 111. Annular slide groove; 12. Ultraviolet germicidal lamp; 13. Actuation handle; 14. Port cover; 15. Wireless charging transmitter module; 2. Touch screen display; 3. Liquid supply tank; 31. Cleaning tank; 32. Conductive tank; 4. Electrode Mechanism; 401. Spiral Liquid Distribution Groove; 402. Permanent Magnet Sheet; 41. Electrode Substrate; 411. Conductive Snap Ring; 412. Electrode Sheet; 413. Lower Spiral Groove; 414. Liquid Distribution Hole; 415. Upper Spiral Groove; 416. One-Way Input Valve; 417. Breaking Needle; 42. Adhesive Substrate; 421. Electro-responsive Adhesive Layer; 43. Replaceable Liquid Bag; 431. One-Way Conductor; 44. Circular Shell; 441. Limiting Groove; 442. Limiting Skirt; 45. Circuit Board; 451. Battery; 452. Bluetooth Module; 453. Signal Light; 46. Top Cover; 461. Interface; 47. Elastic Electromagnetic Sheet; 5. Feeding mechanism; 51. Annular base plate; 52. Annular slide rail; 53. Elastic clamp; 54. Tensioning ring; 541. Elastic part; 542. Clamping part; 55. Drive gear ring; 6. Liquid guiding mechanism; 61. Injection port; 62. Liquid guiding tube; 7. Actuator; 71. Actuating slide bar; 72. Return spring; 8. Liquid supply pump; 9. Two-position three-way solenoid valve. Detailed Implementation
[0018] The embodiments will be described clearly and completely with reference to the accompanying drawings. All other embodiments obtained by those skilled in the art based on the embodiments in this application without creative effort are within the scope of protection of this application.
[0019] Example: This invention provides a therapeutic device for endocrinology. Please refer to [link / reference]. Figure 1 - Figure 16The device includes an electrode mechanism 4, a feeding mechanism 5, a housing mechanism 1, and a touch display screen 2. Several electrode mechanisms 4 are attached in pairs to the neuropathy area of diabetic patients for electrical stimulation therapy. The electrode mechanism 4 has a built-in battery 451 and a Bluetooth module 452 for power supply and wireless control. The feeding mechanism 5 has an overall ring structure to evenly support the electrode mechanisms 4 at different angles. The housing mechanism 1 is used to cover the feeding mechanism 5 and release the electrode mechanisms 4 on the feeding mechanism 5 to the neuropathy area in sequence. The touch display screen 2 is used to control and display the current intensity of each electrode mechanism 4.
[0020] Furthermore, please refer to the following first. Figure 4 - Figure 5 The electrode mechanism 4 is an independent integrated structure, including a circular shell 44 and a top cover 46. The circular shell 44 and the top cover 46 are sealed together by a snap-fit connection. A circuit board 45 is encapsulated within the cavity formed by the two. The circuit board 45 is fixed to a boss structure on the inner wall of the circular shell 44 by screws. An annular limiting skirt 442 is integrally formed on the bottom edge of the circular shell 44. The limiting skirt 442 extends outward along the bottom circumference of the circular shell 44 and is used to press against the edge of the adhesive substrate 42 during assembly to prevent the adhesive substrate 42 from shifting or curling during use.
[0021] Both the battery 451 and the Bluetooth module 452 are fixed to the circuit board 45 by soldering. The two are electrically connected through the copper foil lines on the circuit board 45. The battery 451 is a rechargeable lithium battery, which is used to provide stable power supply to the electrical components of the entire electrode mechanism 4. The Bluetooth module 452 is used to receive external control signals and feed back the working status of the electrode mechanism 4 to the control terminal. The circuit board 45 is also equipped with an indicator light 453. The light-emitting end of the indicator light 453 extends to the outside through the reserved through hole on the top cover 46, which makes it convenient for medical staff to intuitively observe the working status of the electrode mechanism 4.
[0022] Please refer to this first. Figure 14 An electrode substrate 41 is detachably connected to the bottom of the circular housing 44. An annular conductive retaining ring 411 is integrally formed on the top edge of the electrode substrate 41. Correspondingly, a conductive snap-fit groove matching the conductive retaining ring 411 is provided on the inner wall of the bottom of the circular housing 44. During assembly, the conductive retaining ring 411 is aligned with the conductive snap-fit groove and pressed into place, achieving quick positioning and fixation of the electrode substrate 41 and the circular housing 44. Simultaneously, the conductive retaining ring 411 fits tightly against the inner wall of the conductive snap-fit groove, ensuring reliable electrical connection. An adhesive substrate 42 is sandwiched between the circular housing 44 and the electrode substrate 41. An electroresponsive adhesive layer 421 is fixed to its sides by adhesive bonding. This electroresponsive adhesive layer 421 generates adhesion after energization, achieving adhesion and fixation between the electrode mechanism 4 and the patient's skin.
[0023] More specifically, in this embodiment, the substrate of the electroresponsive adhesive layer 421 is medical-grade polyacrylate hydrogel, with graphene conductive filler added to form a composite structure of polymer network and conductive particles. Under the influence of an electric field, conductive particles align in a specific direction, causing the hydrogel molecular chains to contract and forming an adhesive layer on the surface, which adheres closely to the skin. The adhesive strength can be adjusted by voltage. After the electric field disappears, the conductive particles disperse randomly, the hydrogel molecular chains return to their extended state, the surface adhesiveness completely disappears, and it can be easily peeled off.
[0024] Electrode sheet 412 is fixed to the bottom of electrode substrate 41 by conductive adhesive, which is used to generate low-frequency pulse current required for treatment after power is applied; battery 451 supplies power to electrode sheet 412 and electroresponsive adhesive layer 421 through contact and cooperation of circuit board 45, conductive snap groove and conductive snap ring 411.
[0025] Furthermore, please refer to the following first. Figure 6 - Figure 9 The outer walls of the circular shell 44 are symmetrically provided with limiting grooves 441 on both sides. The depth of the grooves matches the diameter of the clamping part 542, ensuring that the clamping part 542 can be fully embedded and fit. The feeding mechanism 5 includes an annular base plate 51.
[0026] The surface of the annular substrate 51 is uniformly distributed with elastic clamps 53 corresponding to the number of electrode mechanisms 4 along the circumferential direction. Each elastic clamp 53 is a circular opening structure, and its inner diameter matches the outer diameter of the circular shell 44, so as to tightly cover the circumferential side of the circular shell 44. The annular substrate 51 is also provided with two sets of symmetrically arranged tension rings 54. The two sets of tension rings 54 are located on the inner ring side and the outer ring side of the annular substrate 51, respectively. Each tension ring 54 includes several integrally formed elastic parts 541 and clamping parts 542. The elastic parts 541 are arc-shaped elastic rod structures, one end of which is fixed to the annular substrate 51, and the other end is connected to the clamping part 542. The clamping part 542 is an arc-shaped rod structure, and its free end extends to the inner side of the opening of the elastic clamp 53 and abuts against the limiting groove 441 of the circular shell 44. In its natural state, the elastic part 541 has a spring force that drives the clamping part 542 to move toward the center of the annular substrate 51, thereby causing the opening of the elastic clamp 53 to contract, so that the elastic clamp 53 fits tightly against the circumferential side of the circular shell 44. At the same time, the clamping part 542 is embedded in the limiting groove 441, limiting the electrode mechanism 4 from both sides, preventing the electrode mechanism 4 from axially or radially shifting during the rotation of the feeding mechanism 5.
[0027] Furthermore, annular slide rails 52 are symmetrically fixed on both end faces of the annular base plate 51 along the circumferential direction. Correspondingly, annular grooves 111 matching the annular slide rails 52 are provided on the inner side walls of the annular shell 11. The annular slide rails 52 and the annular grooves 111 are interlocked to form a sliding fit structure, which can realize the rotational connection between the feeding mechanism 5 and the annular shell 11, and can also limit the axial movement of the feeding mechanism 5 to prevent it from axially moving during rotation.
[0028] A drive gear ring 55 is integrally formed on the outer ring side of the annular base plate 51. The tooth surface of the drive gear ring 55 faces the inside of the annular shell 11. A drive motor is fixed inside the annular shell 11 by a motor bracket. A drive gear is fixed on the output shaft of the drive motor. The drive gear meshes with the drive gear ring 55 to form a gear transmission mechanism. When the drive motor starts, the meshing transmission between the drive gear and the drive gear ring 55 drives the annular base plate 51 to rotate around the central axis of the annular shell 11, thereby realizing the uniform angular rotation of the entire feed mechanism 5 inside the annular shell 11.
[0029] Please refer to this first. Figure 2 and Figure 9 The bottom of the annular shell 11 has a rectangular release port 101 arranged radially. The length and width of the release port 101 are slightly larger than the diameter of the electrode mechanism 4 to ensure that the electrode mechanism 4 can be released smoothly through the release port 101. The two sides of the release port 101 are symmetrically connected to the port cover 14 by hinges to close the release port 101 and prevent dust and impurities from entering the interior of the annular shell 11. The inner side of the port cover 14 is provided with a torsion spring. One end of the torsion spring is fixed to the hinge shaft and the other end is fixed to the inner wall of the annular shell 11, which is used to automatically open when the port cover 14 is unlocked.
[0030] Furthermore, please refer to the following first. Figure 1An actuation handle 13 is fixed at the center of the annular shell 11. The actuation handle 13 is convenient for medical staff to grip and operate. An actuation trigger is provided on the actuation handle 13. The touch screen display 2 is installed on the top end face of the actuation handle 13. The touch screen display 2 is electrically connected to the control board inside the actuation handle 13. It is used to receive operation commands from medical staff and display information such as the current intensity, working status, and battery power of each electrode mechanism 4 in real time. An actuation mechanism 7 is provided inside the actuation handle 13. The actuation mechanism 7 includes an actuation slide rod 71, a return spring 72, and an actuation motor. The actuation slide rod 71 is a cylindrical rod structure. Its outer wall slides in cooperation with the inner wall of the actuation handle 13 and can slide up and down along the axial direction of the actuation handle 13. The top end of the actuation slide rod 71 extends to the bottom of the actuation motor and is connected to the output end of the actuation motor through a screw and nut mechanism. The actuation motor is fixed on the motor base inside the actuation handle 13. The return spring 72 is sleeved on the outside of the actuator slide rod 71. Its top end abuts against the limiting step inside the actuator handle 13, and its bottom end abuts against the annular boss on the actuator slide rod 71. In its natural state, the return spring 72 is compressed, applying an upward elastic force to the actuator slide rod 71, keeping the actuator slide rod 71 in its initial upper position. When the actuator motor starts, the actuator slide rod 71 is driven to move downward against the elastic force of the return spring 72 through the lead screw and nut mechanism. The bottom end of the actuator slide rod 71 extends above the release port 101, opposite to the opening side of the release port 101, and is used to push the port cover 14 open and squeeze the electrode mechanism 4 to release from the feed mechanism 5.
[0031] Furthermore, please refer to the following first. Figure 10 The top of the electrode sheet 412 is provided with a lower spiral groove 413 along the circumferential direction. The lower spiral groove 413 is an arc-shaped groove structure that spirals from the center of the electrode sheet 412 to the edge. Correspondingly, the bottom of the electrode substrate 41 is provided with an upper spiral groove 415 that is completely corresponding to the shape and size of the lower spiral groove 413. After the electrode substrate 41 and the electrode sheet 412 are assembled, the lower spiral groove 413 and the upper spiral groove 415 are aligned to form a closed spiral liquid distribution groove 401, which is used to guide the uniform flow of conductive gel. The bottom of the lower spiral groove 413 is provided with liquid distribution holes 414 that are uniformly connected to the spiral liquid distribution groove 401 along the spiral direction. The liquid distribution holes 414 are cylindrical through holes, and their bottom ends penetrate the bottom surface of the electrode sheet 412, so that the conductive gel in the spiral liquid distribution groove 401 can penetrate to the contact interface between the electrode sheet 412 and the skin through the liquid distribution holes 414. A one-way input valve 416 is provided at the center of the electrode substrate 41. The input end of the one-way input valve 416 is connected to the input point of the vortex liquid distribution tank 401, and the output end faces the replaceable liquid bladder 43. The one-way input valve 416 is provided with an elastic diaphragm, which only allows liquid to flow from the replaceable liquid bladder 43 to the vortex liquid distribution tank 401, preventing the conductive gel from flowing back and causing cross-contamination.
[0032] Please refer to this first. Figure 14 - Figure 15 A replaceable liquid bladder 43 is sandwiched between the circular shell 44 and the electrode substrate 41. The replaceable liquid bladder 43 is a flexible sealed bladder used to temporarily store conductive gel or disinfectant cleaning solution. A puncture needle 417 is integrally formed on the top of the one-way input valve 416. The puncture needle 417 has a conical structure with its tip facing the replaceable liquid bladder 43. It is used to puncture the bottom membrane of the replaceable liquid bladder 43 when it is pressurized, so that the internal liquid can flow into the one-way input valve 416. The replaceable liquid bladder 43 has a one-way flow tube 431 at its top center. The one-way flow tube 431 is a cylindrical tubular structure with a one-way valve inside, allowing liquid to be injected into the replaceable liquid bladder 43 only from the outside. Correspondingly, the top center of the top cover 46 has a mating interface 461 that matches the one-way flow tube 431. The mating interface 461 is a cylindrical through hole with an inner diameter that matches the outer diameter of the one-way flow tube 431. The top of the one-way flow tube 431 passes through a reserved hole on the circular shell 44 and extends into the mating interface 461, so that the external liquid guiding component can be precisely connected to the one-way flow tube 431 through the mating interface 461.
[0033] Furthermore, the cylindrical shell 44 is also fixed with an elastic electromagnetic sheet 47 on the top of the replaceable liquid bladder 43, and the electrode substrate 41 is fixed with a permanent magnet sheet 402 on the bottom of the replaceable liquid bladder 43. The elastic electromagnetic sheet 47 has a magnetic attraction force on the permanent magnet sheet 402 when energized.
[0034] Furthermore, the actuator 7 is also equipped with a liquid guiding mechanism 6, which includes a liquid guiding tube 62 fixed in the actuator slide 71. The bottom end of the liquid guiding tube 62 extends through the actuator slide 71 and is fixed with an injection port 61 that cooperates with the unidirectional guide tube 431. The outer wall of the actuator handle 13 is equipped with a liquid supply tank 3, which includes a cleaning tank 31 and a conductive tank 32. The cleaning tank 31 is filled with disinfectant cleaning solution, and the conductive tank 32 is filled with conductive gel. The actuator handle 13 is also equipped with a liquid supply pump 8 and a two-position three-way solenoid valve 9. The output ends of the cleaning tank 31 and the conductive tank 32 are selectively connected to the input end of the liquid supply pump 8 through the two-position three-way solenoid valve 9, and the output end of the liquid supply pump 8 is connected to the input end of the liquid guiding tube 62.
[0035] Furthermore, an ultraviolet germicidal lamp 12 is fixed to the outer ring side of the inner wall of the annular shell 11. The irradiation side of the ultraviolet germicidal lamp 12 is disposed opposite to the electro-responsive adhesive layer 421 of the electrode mechanism 4, and is used to sterilize the part of the electrode mechanism 4 that comes into contact with the patient.
[0036] Furthermore, a wireless charging transmitter module 15 is fixed on the inner ring side of the inner wall of the annular shell 11, and a wireless charging receiver module that cooperates with the wireless charging transmitter module 15 is fixed inside the top cover 46.
[0037] The endocrinology treatment device of this invention mainly achieves adjunctive treatment of diabetic neuropathy through the automatic supply, electrical response fixation, on-demand fluid delivery, and radio stimulation therapy of the electrode mechanism 4. When using it on a new patient, components in the electrode mechanism 4 that may pose a risk of cross-infection with the previous patient need to be replaced, such as the replaceable fluid sac 43, adhesive substrate 42, and electrode substrate 41. After replacement, several electrode mechanisms 4 are paired up in pairs. The operator holds the outer shell mechanism 1 and installs the electrode mechanism 4 through the release port 101. Specifically, the limiting grooves 441 on both sides of the circular shell 44 connect with the annular base plate 51 in the feeding mechanism 5. The elastic clamp 53 and tension ring 54 work together to achieve fixation. During assembly, the circular shell 44 of the electrode mechanism 4 is aligned with the opening of the elastic clamp 53 and pressed down. The opening of the elastic clamp 53 opens under the pressure of the circular shell 44. When the circular shell 44 is fully embedded in the elastic clamp 53, the elastic part 541 of the tension ring 54 releases its elastic force, driving the clamping part 542 to accurately embed into the limiting groove 441 and make tight contact. At the same time, the elastic clamp 53 contracts under its own elasticity and tightly covers the circumference of the circular shell 44, forming a double fixing structure to ensure that the electrode mechanism 4 is stably supported on the annular base plate 51 and is evenly distributed at an angle along the circumference of the annular base plate 51. At this time, the ultraviolet germicidal lamp 12 inside the annular shell 11 is automatically turned on, and the light directly irradiates the surface of the electro-responsive adhesive layer 421 of the electrode mechanism 4, performing a comprehensive sterilization treatment to kill any bacteria, fungi, or other pathogens that may be attached, thus preventing infection when it is subsequently applied to the patient's skin. Simultaneously, the wireless charging transmitter module 15 on the inner ring side of the inner wall of the annular shell 11 is activated, establishing an energy transmission channel with the wireless charging receiver module inside the top cover 46 through the principle of electromagnetic induction, wirelessly charging the battery 451 built into the electrode mechanism 4. During the charging process, the indicator light 453 on the circuit board 45 flashes red. When the battery 451 is fully charged, the indicator light 453 switches to a solid green, indicating that the electrode mechanism 4 is fully powered and ready for use.
[0038] During treatment, medical staff hold the execution handle 13 and align the release port 101 of the annular shell 11 with the patient's diabetic neuropathy area, ensuring that the release port 101 is parallel and in contact with the skin surface. A drive command is sent by clicking the release button on the touch screen 2 or by directly pulling the trigger on the execution handle 13. This command is processed by the control motherboard and transmitted to the drive motor inside the annular shell 11. The drive motor starts and drives the drive gear on the output shaft to rotate. The drive gear meshes with the drive gear ring 55 on the outer ring side of the annular base plate 51, thereby causing the annular base plate 51 to rotate relative to the annular groove 111 inside the annular shell 11 via the annular slide rails 52 on both sides, achieving an equal-angle rotation of the entire feeding mechanism 5 within the annular shell 11.
[0039] When an electrode mechanism 4 rotates with the annular base plate 51 to directly above the release chamber 101, the position sensor inside the drive motor detects a preset positioning signal, and the drive motor automatically stops rotating, completing the release positioning of the electrode mechanism 4. Subsequently, the actuator motor inside the actuator 7 starts, driving the actuator slide rod 71 to move downward smoothly against the elastic force of the return spring 72 through the screw nut mechanism. The bottom end of the actuator slide rod 71 directly presses the top of the top cover 46 of the electrode mechanism 4, applying a downward thrust. This thrust overcomes the elastic force of the elastic part 541 of the tension ring 54, causing the clamping part 542 to disengage from the limiting groove 441 of the circular shell 44. At the same time, the opening of the elastic clamp 53 is opened, and the electrode mechanism 4 loses its limiting constraint, falls from the release chamber 101, and adheres to the surface of the patient's neuropathic area. After the release of a set of electrode mechanisms 4 is completed, the motor reverses and drives the sliding rod 71 to return upward under the elastic force of the return spring 72. Then the drive motor starts again, driving the feeding mechanism 5 to continue rotating, rotating the next set of electrode mechanisms 4 to the release chamber 101 position, and repeating the above release process until all electrode mechanisms 4 are attached to the lesion area in sequence according to the requirement of even angle distribution.
[0040] When the actuator 7 comes into contact with the electrode mechanism 4, the injection port 61 of the liquid guiding mechanism 6 simultaneously engages with the one-way guide tube 431. During this process, the liquid supply pump 8 starts automatically, and the valve core of the two-position three-way solenoid valve 9 switches to the state of being connected to the conductive tank 32 under electromagnetic drive. The conductive gel in the conductive tank 32 flows into the two-position three-way solenoid valve 9 through the output pipe under the negative pressure suction of the liquid supply pump 8, and then enters the liquid supply pump 8 through the outlet pipe of the two-position three-way solenoid valve 9. After being pressurized by the liquid supply pump 8, it is delivered to the liquid guiding tube 62. The conductive gel in the liquid guiding tube 62 flows along the pipe and is finally output through the injection port 61 at its bottom. At this time, the actuator slide bar 71 moves down slightly again, causing the injection port 61 to precisely engage with the interface 461 on the top cover 46 of the electrode mechanism 4. The injection port 61 is inserted into the one-way guide tube 431, and the conductive gel is injected into the replaceable liquid bladder 43 through the one-way guide tube 431, realizing the addition of conductive gel. When the liquid delivery volume reaches the preset value, the liquid supply pump 8 automatically stops working, and at the same time, the valve core of the two-position three-way solenoid valve 9 switches to the closed state, cutting off the liquid delivery channel and preventing conductive gel leakage.
[0041] During the subsequent process of electrode mechanism 4 adhering to the patient's skin surface, circuit board 45 controls the elastic electromagnetic sheet 47 to be energized at regular intervals. After being energized, the elastic electromagnetic sheet 47 generates a magnetic attraction force, which generates a downward attraction force on the permanent magnet sheet 402 on the electrode substrate 41. Under the action of magnetic attraction force, the elastic electromagnetic sheet 47 bends and deforms downward, directly squeezing the replaceable liquid bladder 43. After being compressed, the internal pressure of the replaceable liquid bladder 43 increases, pushing the bottom film to contact and be punctured by the piercing needle 417. Under the action of pressure, the conductive gel inside pushes the elastic valve core of the one-way input valve 416 to open, and flows into the vortex liquid distribution groove 401 through the gap around the piercing needle 417. Under the guidance of the vortex liquid distribution groove 401, the conductive gel flows evenly from the center to the edge along the vortex direction. During the process, it slowly permeates to the contact interface between the electrode sheet 412 and the skin through the liquid distribution holes 414 evenly distributed along the vortex, forming a uniform conductive dielectric layer to ensure stable and uniform current conduction. At the same time, the circuit board 45 controls the electrical response adhesive layer 421 to be energized. Under the action of the electric field, the electrical response adhesive layer 421 quickly becomes sticky and adheres tightly to the patient's skin surface, firmly fixing the electrode mechanism 4 and preventing the electrode mechanism 4 from shifting or falling off due to the patient's movement during the treatment process.
[0042] After one treatment cycle, medical staff send a power-off command via the touchscreen display 2. Circuit board 45 immediately cuts off the power supply to the electroresponsive adhesive layer 421 and the elastic electromagnetic sheet 47. The adhesive layer 421 quickly loses its stickiness after power is cut off, allowing medical staff to peel the electrode mechanism 4 from the patient's skin and recycle it into the outer casing 1. Before the next treatment cycle, the electrode mechanism 4 is cleaned for reuse on the same patient. Specifically, medical staff send a cleaning command via the touchscreen display 2, restarting the infusion pump 8. Simultaneously, the valve core of the two-position three-way solenoid valve 9 switches to the state connected to the cleaning tank 31. The disinfectant cleaning solution in 31 enters the liquid guide tube 62 through the two-position three-way solenoid valve 9 and the liquid supply pump 8, and is injected into the replaceable liquid sac 43 through the docking port 61 and the one-way guide tube 431. Under pressure, the disinfectant cleaning solution flows into the vortex liquid distribution tank 401 through the puncture needle 417 and the one-way input valve 416, and then flows out through the liquid distribution hole 414, thoroughly rinsing the bottom surface of the electrode plate 412 and the inside of the liquid distribution hole 414 and the vortex liquid distribution tank 401 to remove residual conductive gel and contaminants. After cleaning, the liquid supply pump 8 stops, and the ultraviolet germicidal lamp 12 is then used for sterilization, which is convenient for reuse on the same patient.
[0043] It should be noted that after the fluid conduction and fixation of electrode mechanism 4 are completed, medical staff can adjust the current intensity parameters of each electrode mechanism 4 according to the patient's lesion severity, tolerance, and other actual conditions through the parameter setting interface of the touch screen 2. After the parameters are set, the treatment button is clicked to send the treatment command. This command is transmitted to the circuit board 45 via the Bluetooth module 452. The circuit board 45 controls the battery 451 to supply power to the electrode sheet 412 through the conductive retaining ring 411 and the electrode substrate 41. Under the action of the current, the electrode sheet 412 generates a low-frequency pulse current of preset intensity. This current is conducted to the diabetic neuropathy area of the patient through the conductive gel layer, stimulating the nerve endings, improving nerve conduction function, and reducing symptoms such as pain and numbness. During the treatment, the real-time current intensity data of each electrode mechanism 4 is fed back to the control motherboard through the Bluetooth module 452 and displayed in real time on the touch screen 2. Medical staff can observe the data displayed on the touch screen 2 and combine it with the patient's real-time reaction, such as whether there is stinging or discomfort, and adjust the current intensity parameters of the corresponding electrode mechanism 4 at any time through the touch screen 2 to ensure the safety and effectiveness of the treatment.
[0044] After the treatment is completed, the medical staff clicks the stop button to send a stop command. The circuit board 45 controls the battery 451 to stop supplying power to the electrode 412, and the electrode 412 stops generating current, thus completing the treatment process.
[0045] This invention utilizes the cooperation of the feeding mechanism 5 and the execution mechanism 7 to form an automated electrode release system for the electrode mechanism 4, eliminating the need for medical personnel to manually attach each electrode piece individually, significantly reducing operational difficulty. This invention abandons the traditional medical pressure-sensitive adhesive layer, employing an electroresponsive adhesive layer 421 as the fixing structure of the electrode mechanism 4. This adhesive layer only becomes sticky when energized, ensuring a firm fit against the patient's skin. This avoids skin irritation and other problems caused by traditional adhesive residue, and is particularly suitable for the weak healing ability and high sensitivity of diabetic patients' skin, significantly reducing the risk of skin damage and infection. Furthermore, the on / off state of the adhesive is remotely controlled via wireless signals, eliminating the need for manual operation, further improving ease of use and reducing the workload of medical personnel.
[0046] This invention utilizes a vortex-shaped liquid distribution groove 401 formed by the mating of a lower vortex groove 413 and an upper vortex groove 415. Combined with liquid distribution holes 414 evenly distributed along the vortex, after the conductive gel is injected, it flows evenly from the center to the edge along a fixed path under the guidance of the vortex-shaped liquid distribution groove 401. Then, it slowly permeates through the liquid distribution holes 414 to the contact interface between the electrode pad 412 and the skin, forming a uniformly thick and fully covered conductive dielectric layer. This solves the problems of uneven application and improper dosage caused by traditional manual application of conductive gel, effectively avoiding the stinging sensation caused by obstructed current conduction and localized current concentration, ensuring the stability and uniformity of current conduction, and improving the comfort and effectiveness of treatment. Simultaneously, the replaceable liquid sac 43 adopts a disposable design, allowing for direct replacement after use and avoiding cross-infection caused by repeated use.
[0047] This invention establishes a wireless communication link through a Bluetooth module 452, and the electrode mechanism 4 is independently powered by a built-in battery 451, freeing it from the constraints of external power cords. Patients can move freely during treatment, greatly improving user comfort and realizing the automation, precision, and safety of electrical stimulation therapy for diabetic neuropathy, thus possessing good clinical application value.
[0048] The above description is merely the best implementation method adopted in light of current practical needs, but the scope of protection of this application is not limited thereto.
Claims
1. A therapeutic device for endocrinology, characterized in that, include: Electrode mechanism (4), a plurality of said electrode mechanisms (4) are attached in pairs to the neuropathy area of diabetic patients for electrical stimulation therapy. The electrode mechanism (4) has a built-in battery (451) and Bluetooth module (452) for power supply and wireless control. The feeding mechanism (5) has an overall ring structure and is used to support the electrode mechanism (4) at equal angles. The outer shell mechanism (1) is used to cover the feeding mechanism (5) and sequentially release the electrode mechanism (4) on the feeding mechanism (5) to the neuropathic area; A touch screen (2) is used to control and display the current intensity of each electrode mechanism (4).
2. The endocrinology treatment device according to claim 1, characterized in that, The electrode mechanism (4) includes a circular shell (44) and a top cover (46). A circuit board (45) is encapsulated between the circular shell (44) and the top cover (46). A limiting skirt (442) for pressing and bonding the substrate (42) is fixed at the bottom of the circular shell (44). The battery (451) and the Bluetooth module (452) are both mounted on the circuit board (45). An indicator light (453) is also provided on the circuit board (45). The bottom of the circular shell (44) is provided with an electrode substrate (41), the top of the electrode substrate (41) is fixed with a conductive retaining ring (411), and the bottom of the circular shell (44) is provided with a conductive snap groove that matches the conductive retaining ring (411); an adhesive substrate (42) is sandwiched between the circular shell (44) and the electrode substrate (41), and an electroresponsive adhesive layer (421) is fixed on the side of the adhesive substrate (42) to generate adhesion after being energized; The bottom of the electrode substrate (41) is fixed with an electrode sheet (412) for generating current after being energized. The battery (451) supplies power to the electrode sheet (412) and the electro-responsive adhesive layer (421) through a conductive retaining ring (411).
3. The endocrinology treatment device according to claim 2, characterized in that, Limiting grooves (441) are symmetrically provided on both sides of the circular shell (44). The feeding mechanism (5) includes an annular base plate (51), on which elastic clamps (53) corresponding to the number of electrode mechanisms (4) are provided. The elastic clamps (53) cover the circumferential side of the circular shell (44). The annular base plate (51) is also provided with two sets of symmetrically arranged tension rings (54). The tension rings (54) include an elastic part (541) and a clamping part (542). The clamping part (542) extends into the elastic clamp (53) and abuts against the limiting groove (441). The elastic part (541) has an elastic force that drives the clamping part (542) and the elastic clamp (53) to approach the circular shell (44).
4. The endocrinology treatment device according to claim 3, characterized in that, The annular base plate (51) is also symmetrically fixed with an annular slide rail (52) and a drive gear ring (55) on both sides. The outer shell mechanism (1) includes an annular shell (11), which has an annular shell structure. The annular shell (11) is provided with an annular groove (111) that matches the annular slide rail (52). The feeding mechanism (5) is rotatably connected to the annular shell (11) through the annular groove (111) and the annular slide rail (52). The annular shell (11) is provided with a drive motor that drives the drive gear ring (55). The feeding mechanism (5) is rotated at equal angles within the annular shell (11) by the drive motor. The bottom of the annular shell (11) is provided with a release port (101), and the two sides of the release port (101) are symmetrically rotatably connected with port cover plates (14).
5. The endocrinology treatment device according to claim 4, characterized in that, An execution handle (13) is fixed at the center of the annular shell (11). The touch screen (2) is fixed at the top of the execution handle (13). An execution mechanism (7) is provided inside the execution handle (13). The execution mechanism (7) includes an execution slide rod (71) slidably connected to the bottom of the execution handle (13). A return spring (72) is clamped between the execution slide rod (71) and the execution handle (13). An execution motor is provided inside the execution handle (13) to drive the execution slide rod (71) to move downward against the elastic force of the return spring (72). The bottom end of the execution slide rod (71) is set opposite to the opening side of the release port (101).
6. The endocrinology treatment device according to claim 5, characterized in that, The electrode sheet (412) has a lower vortex groove (413) at the top and an upper vortex groove (415) corresponding to the lower vortex groove (413) at the bottom. The lower vortex groove (413) and the upper vortex groove (415) are aligned to form a vortex liquid distribution groove (401). The lower vortex groove (413) has a liquid distribution hole (414) that communicates with the vortex liquid distribution groove (401). The electrode substrate (41) is provided with a one-way input valve (416) that communicates with the input point of the vortex liquid distribution tank (401). A replaceable liquid bladder (43) is also sandwiched between the circular shell (44) and the electrode substrate (41). The top of the one-way input valve (416) is provided with a piercing needle (417) that cooperates with the replaceable liquid bladder (43). The top of the replaceable liquid bladder (43) is provided with a one-way guide tube (431). The top of the top cover (46) is provided with a matching interface (461) corresponding to the one-way guide tube (431). The top of the one-way guide tube (431) passes through the circular shell (44) and extends into the matching interface (461).
7. The endocrinology treatment device according to claim 6, characterized in that, The circular shell (44) has an elastic electromagnetic plate (47) fixed on top of the replaceable liquid bladder (43), and the electrode substrate (41) has a permanent magnet plate (402) fixed on the bottom of the replaceable liquid bladder (43). The elastic electromagnetic plate (47) has a magnetic attraction force on the permanent magnet plate (402) when energized.
8. The endocrinology treatment device according to claim 6, characterized in that, The actuator (7) is also provided with a liquid guiding mechanism (6), which includes a liquid guiding tube (62) fixed in the actuator slide (71). The bottom end of the liquid guiding tube (62) extends through the actuator slide (71) and is fixed with an injection port (61) that cooperates with the unidirectional guide tube (431). The outer wall of the actuator handle (13) is provided with a liquid supply tank (3), which includes a cleaning tank (31) and a conductive tank (32). The cleaning tank (31) is filled with disinfectant cleaning solution, and the conductive tank (32) is filled with conductive gel. The actuator handle (13) is also provided with a liquid supply pump (8) and a two-position three-way solenoid valve (9). The output ends of the cleaning tank (31) and the conductive tank (32) are selectively connected to the input end of the liquid supply pump (8) through the two-position three-way solenoid valve (9). The output end of the liquid supply pump (8) is connected to the input end of the liquid guide tube (62).
9. The endocrinology treatment device according to claim 4, characterized in that, An ultraviolet germicidal lamp (12) is also fixed on the outer ring side of the inner wall of the annular shell (11). The irradiation side of the ultraviolet germicidal lamp (12) is arranged opposite to the electro-responsive adhesive layer (421) of the electrode mechanism (4) for sterilizing the part of the electrode mechanism (4) that comes into contact with the patient.
10. The endocrinology treatment device according to claim 4, characterized in that, The inner ring side of the inner wall of the annular shell (11) is also fixed with a wireless charging transmitter module (15), and the top cover (46) is fixed with a wireless charging receiver module that cooperates with the wireless charging transmitter module (15).